Potential New Drug For Neurodegenerative Disease

Links shared publicly online about this topic.

  • 884
    total visits

Potential New Drug For Neurodegenerative Disease

medicalnewstoday.com

Scientists have discovered a small molecule that helps human cells get rid of the misfolded, disfigured proteins implicated in Alzheimer's disease and other neurodegenerative ailments. This potent

View full resource at medicalnewstoday.com

Tags: Neurology, Alzheimer's Disease, Disease and Condition, Protein, Drug, Scientist

  • Share

Most Recently Shared on September 10, 2010 at 2:00 pm By:

mnt_genetics MNT Genetics News

Potential New Drug For Neurodegenerative Disease http://mnt.to/3JwS #genetics

2 years ago...

Also Shared By:

MNT Alzheimer's News MNT Alzheimer's News

MNT Neurology News MNT Neurology News

Hopkins Launches New ALS Research Center with $25 Million Gift - 03/21/2012

hopkinsmedicine.org — “A $25 million gift has enabled Johns Hopkins to establish a new center to develop novel therapies for the neurodegenerative disease known as amyotrophic lateral sclerosis, Lou Gehrig’s disease, or ALS. Much of the center’s research will focus on using stem cells individually derived from ALS patients to develop new model systems to investigate how nerve cells degenerate, as tools to screen new drug therapies, and to develop stem cell therapies as transplants to potentially slow or reverse the diView full resource at hopkinsmedicine.org

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 2:32 pm By:

HopkinsMedNews JohnsHopkinsMedicine Health News

A $25 million gift has enabled Johns Hopkins to establish a new #ALS center. http://t.co/xeL7Nkl1

2 months ago...

Potential Predictive Test For Alzheimer's Disease

medicalnewstoday.com — “New research in humans reveals that the so-called FKBP52 protein may prevent the Tau protein from turning pathogenic. This may prove significant for the development of new Alzheimer's drugs and foView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 7:05 am By:

AIDSmeds - Top Stories : Marijuana and its CD4 Receptors: A New HIV Treatment Strategy? - by Tim Horn

aidsmeds.com — “Drugs that target one of the two cellular receptors stimulated by the active ingredient in marijuana may prove to be effective at blocking a form of HIV that has been linked to faster disease progression during late stages of the infection.View full resource at aidsmeds.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 12:43 am By:

AIDSmeds AIDSmeds Health News

Top Stories : Marijuana and its CD4 Receptors: A New #HIV Treatment Strategy? http://t.co/4BTZIoED #AIDS

2 months ago...

A new approach to faster anticancer drug discovery

labspaces.net — “Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current online issue of the Proceedings of tView full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 3:00 pm By:

LabSpaces Brian Krueger Health News

A new approach to faster anticancer drug discovery - http://t.co/xyrklY00

2 months ago...

Potential Alzheimer's disease drug slows damage and symptoms in animal model

sciencedaily.com — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a new study. The compound epothilone D is effective in preventing further neurological damage and improving cognitive performance in a mouse model of Alzheimer's disease (AD). The results establish how the drug might be used in early-stage AD patients.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 3:52 am By:

Alzheimer_OW OrganizedWisdom AD OW Health

Potential Alzheimer's disease drug slows damage and symptoms in animal model: A compound that previously progres... http://t.co/feX2ARxC

2 months ago...

A new approach to faster anticancer drug discovery

medicalxpress.com — “Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 8:12 pm By:

physorg_health PhysOrg Health News Health News

A new approach to faster anticancer drug discovery http://t.co/nMTty1LW

2 months ago...

Researchers Studying New Treatment for Alzheimer's Disease | Rush

rush.edu — “Neurological experts from the Rush University Medical Center are studying a potential, new treatment for patients with dementia due to Alzheimers disease. Rush is the only site in the U.S. offering the clinical trial for a drug treatment called MSDC-0160.View full resource at rush.edu

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 6:08 pm By:

Lifesaving Overdose Antidote Should Be Widely Available | Healthland | TIME.com

healthland.time.com — “Naloxone — the drug that safely reverses the potentially fatal effects of an opioid overdose — has successfully reversed more than 10,000 overdoses since 1996, according to new data from the Centers for Disease Control and Prevention (CDC).View full resource at healthland.time.com

  • View Related
  • Share

Most Recently Shared on February 17, 2012 at 2:01 pm By:

TIMEHealthland TIMEHealthland Health Site

A lifesaving overdose reversal drug should be more available | http://t.co/2Htlvvyv

3 months ago...

Inflammation In Brain Inhibited By New Class Of Potential Drugs

medicalnewstoday.com — “Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 16, 2012 at 9:05 am By:

MedicalFeed MedicalFeed Health News Feed

Inflammation In Brain Inhibited By New Class Of Potential Drugs: Scientists at Emory… http://t.co/vkuxs071

3 months ago...

New hope for diseases of protein folding such as Alzheimer’s, Parkinson’s diseases, ALS, cancer and diabetes

sciencedaily.com — “Two related studies offer new strategies for tackling the challenges of preventing and treating diseases of protein folding, such as Alzheimer's, Parkinson's and Huntington's diseases, ALS, cystic fibrosis, cancer and type 2 diabetes. The research identifies new genes and pathways that prevent protein misfolding and toxic aggregation, keeping cells healthy, and also identifies small molecules with therapeutic potential that restore health to damaged cells, providing new targets for drug developmView full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on January 9, 2012 at 11:40 am By:

GFMelissa Melissa Patient Expert

New hope for protein folding diseases such as Alzheimer’s, Parkinson’s: http://t.co/VuOvO2gv

4 months ago...

Breast-Cancer Drugs Raise Hopes - WSJ.com

online.wsj.com — “Two drugs significantly extend the time that women with advanced breast cancer can live without their tumors growing, potentially changing the landscape for 80% of patients with the disease, according to two separate studies.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on December 8, 2011 at 3:18 am By:

Spectrum seeks FDA IND approval for SPI-014 to treat hyperphosphatemia

news-medical.net — “Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 5, 2011 at 2:16 pm By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: Spectrum seeks FDA IND approval for SPI-014 to treat hyperphosphatemia: Spectrum Pharmaceuticals ... http://t.co/2sR2xfK8

5 months ago...

Older home health care patients are prescribed PIMs three times higher than others

news-medical.net — “Older adults receiving home health care may be taking a drug that is unsafe or ineffective for someone their age. In fact, nearly 40 percent of seniors receiving medical care from a home health agency are taking at least one prescription medication that is considered potentially inappropriate to seniors, a new study in the Journal of General Internal Medicine has revealed.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 22, 2011 at 5:35 am By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Older home health care patients are prescribed PIMs three times higher than others: Older adults... http://t.co/kqWvXDyk

6 months ago...

One-on-One with Dan Adelman of Alvine Pharmaceuticals - San Francisco Business Times

bizjournals.com — “A gluten-free diet is great for celiac disease patients, but even the strictest ...View full resource at bizjournals.com

  • View Related
  • Share

Most Recently Shared on November 21, 2011 at 3:12 pm By:

shelleycasewww.glutenfreeda.com and "Ask Shelley Case" at www.befreeforme.com.

In recognition of Shelley’s major contributions to the celiac community and dedication to educating health professionals and individuals with celiac disease in Canada and the United States, she was awarded the Queen Elizabeth Golden Jubilee Medal. Shelley also recently received the Canadian Celiac Association’s Honourary Life Member Award." /> Shelley Case, RD Nutritionist, Dietitian, and Active Health Library

Drug for celiac disease- update on research @ http://t.co/Jp55lWSK via @SFBusinessTimes #celiac #glutenfree

6 months ago...

Mouse Model Offers Potential New Drug Target In Lou Gehrig's Disease

medicalnewstoday.com — “Two proteins conspire to promote a lethal neurological disease, according to a study published online this week in the Journal of Experimental Medicine*.Amyotrophic lateral scleroView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 15, 2011 at 9:05 am By:

mnt_multiplescl MNT Multiple Scl Health News

Mouse Model Offers Potential New Drug Target In Lou Gehrig's Disease http://t.co/21HomgI9 #multiplesclerosis

6 months ago...

Advertisement